These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas. Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867 [TBL] [Abstract][Full Text] [Related]
6. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028 [TBL] [Abstract][Full Text] [Related]
7. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma. Thomas DG; Giordano TJ; Sanders D; Biermann JS; Baker L Clin Cancer Res; 2002 Mar; 8(3):788-93. PubMed ID: 11895910 [TBL] [Abstract][Full Text] [Related]
8. Amplification of the gli gene in childhood sarcomas. Roberts WM; Douglass EC; Peiper SC; Houghton PJ; Look AT Cancer Res; 1989 Oct; 49(19):5407-13. PubMed ID: 2766305 [TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 expression in human soft-tissue sarcomas is related to epithelial differentation. Lassus P; Ristimäki A; Huuhtanen R; Tukiainen E; Asko-Seljavaara S; Andersson LC; Miettinen M; Blomqvist C; Haglund C; Böhling T Anticancer Res; 2005; 25(4):2669-74. PubMed ID: 16080510 [TBL] [Abstract][Full Text] [Related]
10. Preclinical analysis of tasidotin HCl in Ewing's sarcoma, rhabdomyosarcoma, synovial sarcoma, and osteosarcoma. Garg V; Zhang W; Gidwani P; Kim M; Kolb EA Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5446-54. PubMed ID: 17875774 [TBL] [Abstract][Full Text] [Related]
11. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells. García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936 [TBL] [Abstract][Full Text] [Related]
12. Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma. Ito H; Duxbury M; Benoit E; Farivar RS; Gardner-Thorpe J; Zinner MJ; Ashley SW; Whang EE Biochem Biophys Res Commun; 2004 May; 318(2):594-600. PubMed ID: 15120641 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. Scotlandi K; Manara MC; Nicoletti G; Lollini PL; Lukas S; Benini S; Croci S; Perdichizzi S; Zambelli D; Serra M; García-Echeverría C; Hofmann F; Picci P Cancer Res; 2005 May; 65(9):3868-76. PubMed ID: 15867386 [TBL] [Abstract][Full Text] [Related]
14. Plasminogen activators and their inhibitor in osteosarcomas and other bone tumors. Häkel C; Ueda Y; Tsuchya H; Herrera A; Blasius S; Roessner A Zentralbl Pathol; 1994 Nov; 140(4-5):363-9. PubMed ID: 7826985 [TBL] [Abstract][Full Text] [Related]